ライフサイエンスコーパス: per day

1 ly) with dietary sodium restriction (60 mmol per day).

2 y > 40 mg methylprednisolone [or equivalent] per day).

3 o 2.78 [orthopedic surgery] returning visits per day).

4 tion (RR, 0.89 per day; 95% CI, 0.84 to 0.94 per day).

5 ting rates (the number of bites, per person, per day).

6 ) current smokers (n = 104, >= 10 cigarettes per day).

7 hydroartemisinin-piperaquine (4 and 18 mg/kg per day).

8 nce of polypharmacy (>= 5 prescription drugs per day).

9 1.80 [orthopedic surgery] new patient visits per day).

10 termined from longitudinal observations (5-6 per day).

11 escalation (approximately 30 mg per kilogram per day).

12 plants with a peak growth rate up to 100 cm per day.

13 ostnatal months, and reported breastfeedings per day.

14 9 individuals who took at least 12 000 steps per day.

15 purchases ranging from -4.9 to -12.5 ounces per day.

16 nd mortality after adjusting for total steps per day.

17 ), and higher morphine milligram equivalents per day.

18 9 and 2017, reaching a staggering 130 deaths per day.

19 rnover of billions of senescent erythrocytes per day.

20 ugated bilirubin increased 4.3 +/- 1.1 mg/dL per day.

21 xicities were observed at doses of 30-400 mg per day.

22 CI, 0.44-0.89) with greater than one serving per day.

23 d providing an average of 13.8 hours of care per day.

24 nificant risks even at doses of 5 mg or less per day.

25 rol), 1000, 2000, or 4000 IU of vitamin D(3) per day.

26 juvenile kelp removed, on average, per m(2) per day.

27 nd vegetable availability below 400 g/person per day.

28 abundances increased with brushing frequency per day.

29 reduction to 100 mg per day and 16% to 50 mg per day.

30 by processing single cells as many as 10(8) per day.

31 extension to 36 Gy in 1.8-Gy fractions twice per day.

32 r older, and smoked at least five cigarettes per day.

33 for example, by analyzing total sitting time per day.

34 or equal to 20 mg per day vs less than 20 mg per day.

35 nts with dietary intake of less than 1200 mg per day.

36 nsumed [Formula: see text] cups of tap water per day.

37 d's population takes at least one medication per day.

38 -11plex), ~77 single cells could be analyzed per day.

39 reduced sodium excretion from 160 to 64 mmol per day.

40 in Italy and had been walking up to 4 miles per day.

41 xponential growth rates of approximately 38% per day.

42 CI, 0.41-0.87) with greater than one serving per day.

43 a mean of 5.7 days for a mean of 14.4 hours per day.

44 increasing testing capacity by 1000 samples per day.

45 and a maximum of 73.9% of juveniles per m(2) per day.

46 isk profile was observed at a dose of 150 mg per day.

47 es cause tens of thousands of nicks per cell per day.

48 with a baseline activity level of 5624 steps per day.

49 y products was estimated at 0.16 mug/kg b.w. per day.

50 s of a coffee-like placebo beverage (n = 64) per day.

51 the sertraline group vs 0.47 -log(10) CFU/mL per day [0.40-0.54] in the placebo group; p=0.59), as wa

52 ng length of stay (adjusted odds ratio [aOR] per day, 1.03; P = .006), exposure to multiple classes o

53 25 kg/m2, 10% and 18% for >=2 cups of coffee per day, 13% and 7% for moderate alcohol intake, 8% and

54 e 7 days of supervised primaquine (1.0 mg/kg per day), 14 days of supervised primaquine (0.5 mg/kg pe

55 .5%) for glucocorticoid dose of 5 mg or less per day, 14.4% (CI, 13.8% to 15.1%) for greater than 5 t

56 units requested was 36.3 (range 8-57) units per day; 14 (range 0-30) were received.

57 ceive either: 1) 2000 IU vitamin D-3 (Vit D) per day; 2) 4000 mg CLA per day; 3) both Vit D (2000 IU/

58 55 individuals who took less than 4000 steps per day; 21.4 per 1000 person-years (488 deaths) for the

59 verage of 1.34 additional new patient visits per day (295 per year) were required to recover scribe c

60 were assigned to receive FA (400 or 800 mug per day), 3 g creatine per day, 400 mug FA + 3 g creatin

61 vitamin D-3 (Vit D) per day; 2) 4000 mg CLA per day; 3) both Vit D (2000 IU/d) and CLA (4000 mg/d);

62 osed to a dose of TBT (0.5 mg/kg body weight per day; 3.07 muM) below the current developmental no ob

63 ned to receive either fenfluramine 0.2 mg/kg per day (39), fenfluramine 0.7 mg/kg per day (40) or pla

64 2 mg/kg per day (39), fenfluramine 0.7 mg/kg per day (40) or placebo (40).

65 g) for the first 2 weeks, followed by 800 mg per day (400 mg twice a day) for 22 weeks.

66 ve FA (400 or 800 mug per day), 3 g creatine per day, 400 mug FA + 3 g creatine per day, or placebo.

67 tients, an average of 2.15 additional visits per day (472 per year) were required (range, 1.65 [cardi

68 ar Dig Rush iPad game (prescribed for 1 hour per day 5 days per week) plus spectacle wear if needed (

69 1727 individuals who took 4000 to 7999 steps per day; 6.9 per 1000 person-years (176 deaths) for the

70 .8%) for glucocorticoid dose of 5 mg or less per day, 8.1% (CI, 7.0% to 9.3%) for greater than 5 to 1

71 tatewide social distancing measures, by 0.9% per day (95% CI -1.4% to -0.4%; P < 0.001).

72 uted mortality growth rate decreased by 2.0% per day (95% CI -3.0% to -0.9%; P < 0.001).

73 1.1% increased odds of vascular complication per day ([95% CI, 0.0%-2.3%] P=0.05).

74 similar between groups (0.43 -log(10) CFU/mL per day [95% CI 0.37-0.50] in the sertraline group vs 0.

75 tions did not change throughout 2019 (-0.01% per day [95% CI: -0.04% to +0.02%]; p = 0.50), January 2

76 o +0.5%]; p = 0.31), or February 2020 (+0.7% per day [95% CI: -0.6% to +2.0%]; p = 0.27).

77 % to +0.02%]; p = 0.50), January 2020 (-0.5% per day [95% CI: -1.6% to +0.5%]; p = 0.31), or February

78 ine in hospitalizations in March 2020 (-5.9% per day [95% CI: -7.6% to -4.3%]; p < 0.001).

79 ted treatment difference, -1.9% (-27 minutes per day); 95% CI, -2.8% to -1.1% [-40 to -16 minutes per

80 wide restrictions on internal movement (0.1% per day; 95% CI -0.04% to 0.3%; P = 0.14), but there is

81 r) and longer acute-phase duration (RR, 0.89 per day; 95% CI, 0.84 to 0.94 per day).

82 1 percentage points [equivalent to 2.6 hours per day]; 95% confidence interval, 7 to 14; P<0.001).

83 etes, liraglutide, at a dose of up to 1.8 mg per day (added to metformin, with or without basal insul

84 0.2 mg/kg per day, or fenfluramine 0.7 mg/kg per day, added to existing antiepileptic agents for 14 w

85 g per day) or daily deferasirox (20-40 mg/kg per day) administered as dispersible tablets, both with

86 ally in 28-day cycles, with LDAC (20 mg/m(2) per day) administered subcutaneously on days 1 to 10.

87 ors, and the other half attributed one point per day alive free of organ support up to a predefined t

88 , the kidney filters nearly 200 g of glucose per day, almost all of which is reabsorbed.

89 median of 8 staff illness episodes was seen per day; almost 10% (n = 29) resulted in hospitalization

90 o 18.5%, respectively); MME of 90 or greater per day also decreased in both groups (15.0% to 4.7% and

91 At a throughput of 24 single cells per day, an average of 256 proteins was identified from

92 Compared with an intake of 175 mg per day, an intake of 1000 mg per day was associated wit

93 nce of human health outcomes are $66 million per day and $116 million per day during peak pollutant f

94 required erlotinib dose reduction to 100 mg per day and 16% to 50 mg per day.

95 e mean doses were 19.2+/-1.8 mg per kilogram per day and 29.5+/-3.6 mg per kilogram per day, respecti

96 pective candidate and NDD arrival rates of 2 per day and 3 per month, and delay times for access to D

97 Accelerometer-measured number of steps per day and 3 step intensity measures (extended bout cad

98 standing on the air-lifted platform for 2 h per day and blood samples were taken periodically to mea

99 would see on average 1.5 fewer HFSS adverts per day and decrease caloric intake by 9.1 kcal (95% UI

100 ogical symptoms, number of cigarettes smoked per day and drinking status were related to suicide atte

101 arried couple, job satisfaction, sleep hours per day and sleep quality were negative factors of burno

102 It is unclear whether the number of steps per day and the intensity of stepping are associated wit

103 e more likely to exceed MME of 90 or greater per day and to be prescribed 2 or more opioid agents and

104 Patients received dabrafenib 150 mg twice per day and trametinib 2 mg per day continuously until d

105 rted smoking and number of cigarettes smoked per day and with ex-smokers by the age at which they had

106 llow-up in the CGM group vs 4.7% (68 minutes per day) and 4.9% (70 minutes per day), respectively, in

107 s lucimarinus under standard- (1.3 divisions per day) and limited-light (0.41 divisions per day) nutr

108 esign, of vitamin D(3) (at a dose of 2000 IU per day) and marine n-3 fatty acids (at a dose of 1 g pe

109 of intravenous amphotericin B (0.7-1.0 mg/kg per day) and oral fluconazole (starting at 800 mg/day) w

110 foraging gains (64% reduction in mass gained per day) and reduced flight time by 14%.

111 (8 mg/m(2) per day), etoposide (100 mg/m(2) per day), and cytarabine (1000 mg/m(2) per day on days 1

112 cially low-intensity smoking (1-9 cigarettes per day), and preterm birth are still inconsistent and a

113 ng (having ever smoked regularly, cigarettes per day, and duration smoked) with GM and WM (GM N = 19,

114 pack-years, years as a smoker, packs smoked per day, and hours as a passive smoker per week.

115 more time in direct patient care per visit, per day, and per year.

116 g vertebrates produce large numbers of calls per day, and the calls have prominent roles in social in

117 39 individuals who took 8000 to 11 999 steps per day; and 4.8 per 1000 person-years (82 deaths) for t

118 linical benefit of 600 mg of alectinib twice per day as a first-line treatment for ALK-positive non-s

119 + J, and reported 6.9 +/- 2.1 breastfeedings per day at 1 postnatal month.

120 concentrations changed by mean = -160 pg/mL per day at 24 hours, but no further after Day 4.

121 st-LT (SALT) score (range: 0-11): >10 drinks per day at initial hospitalization (+4 points), multiple

122 1) treating patients with multiple sessions per day at optimally spaced intervals, 2) applying a hig

123 vels less than 70 mg/dL was 5.1% (73 minutes per day) at baseline and 2.7% (39 minutes per day) durin

124 oral self-administration of 1.5 g/kg ethanol per day beginning prior to pregnancy and extending throu

125 navir (100 mg ritonavir and 800 mg darunavir per day), both with investigator-selected nucleoside rev

126 labor not only limits the amount of training per day, but also introduces several sources of variabil

127 ery 4 weeks) or oral azathioprine (2-3 mg/kg per day) by an independent statistician using computer-g

128 ers of cells, often in excess of 100 million per day, continually infiltrate wound dressings.

129 nib 150 mg twice per day and trametinib 2 mg per day continuously until disease progression or intole

130 hers who had received 400 IU of vitamin D(3) per day (control group).

131 imum distribution with a mean of 0.5% energy per day (corresponding to TFA intake only from nonindust

132 d reduce the number of cigarettes they smoke per day (CPD) over their lifetime.

133 e and smoking intensity (cotinine/cigarettes per day (CPD)) shared chromosome 19 and chromosome 4 loc

134 Smoking 1-10 cigarettes per day (CPD, 0.5 pack) was significantly associated wit

135 phine milligram equivalents of 50 or greater per day decreased for women with and without coprescript

136 100 mg/kg per day) or deferasirox (<40 mg/kg per day; deferasirox is not registered for use in childr

137 reduced-calorie diet, aiming for a 500 kcal per day deficit from baseline energy intake, and increas

138 n (adjusted mortality rate ratio [aMRR] 1.05 per day delay, 95% CI 1.00 to 1.09, p=0.040) and later s

139 ral solution of either deferiprone (30 mg/kg per day divided into two equal doses) or placebo for 18

140 The higher 0.8 meq/kg of lean body wt per day dose of NaHCO(3) may be a reasonable choice for

141 tween the 25 and 250 mug/kg body weight (BW) per day doses.

142 DON to the coastal ocean per km of shoreline per day during late summer.

143 mes are $66 million per day and $116 million per day during peak pollutant formation periods in summe

144 ers who had received 4400 IU of vitamin D(3) per day during pregnancy (vitamin D group) would have a

145 ed 1-2, 3-5, 6-9, 10-19, and >=20 cigarettes per day during the first trimester compared with mothers

146 es per day) at baseline and 2.7% (39 minutes per day) during follow-up in the CGM group vs 4.7% (68 m

147 r mortality after adjustment for total steps per day (eg, highest vs lowest quartile of peak 30 caden

148 avenous infusions of mitoxantrone (8 mg/m(2) per day), etoposide (100 mg/m(2) per day), and cytarabin

149 non-White) who wore the smartwatch >=5 hours per day for >=30 days.

150 Health Organization recommends 20 mg of zinc per day for 10 to 14 days for children with acute diarrh

151 patients were challenged with 4 g of gluten per day for 10 weeks and 24 non-coeliac patients served

152 ant NSCLC were treated with erlotinib 150 mg per day for 2 years after standard adjuvant chemotherapy

153 o investigate the effects of Ang II (3 mg/kg per day for 3 weeks) on AF susceptibility and atrial fun

154 where mice underwent 18-h sleep deprivation per day for 5 consecutive days, we performed an extensiv

155 Patients were treated with letrozole 2.5 mg per day for 6 months before surgery.

156 oadjuvant single-agent oral talazoparib once per day for 6 months without chemotherapy produced subst

157 sion study and treated with voxelotor 900 mg per day for 6 months.

158 acheally administrated with 500 ng of rIL-33 per day for four consecutive days or were sensitized and

159 old woman who smoked more than 20 cigarettes per day for over 20 years, consumed 3 or more alcoholic

160 nib twice daily for 2 days, followed by 4 mg per day for the remaining 7 days.

161 hets of ready-to-use therapeutic food (RUTF) per day for those with mid-upper arm circumference (MUAC

162 < 11.5 cm and/or edema, and 1 sachet of RUTF per day for those with MUAC 11.5 to <12.5 cm.

163 ombination with carbidopa (25 mg three times per day) for 80 weeks (early-start group) or placebo for

164 ore bright red glasses for five 1-hr periods per day, for 5 days.

165 associated with reduced heparin dose changes per day from 11 +/- 4 to 2 +/- 1 (p < 0.001), smaller he

166 ssignment was 1:1 to gefitinib 250 mg orally per day (Gef) or gefitinib 250 mg orally per day plus pe

167 unding-line retreat rates of 40 to 50 meters per day (>10 kilometers per year) are inferred during re

168 nalysis showed that the number of cigarettes per day has a specific genetic background distinct from

169 We applied per-day hazard ratios (HRs) for cancer progression that

170 CI, 0.44-0.55]), as was taking 12 000 steps per day (HR, 0.35 [95% CI, 0.28-0.45]).

171 nts received 100 mg oral acalabrutinib twice per day in 28-day cycles until disease progression or un

172 nib orally at a dose of at least 600 mg once per day in a capsule.

173 EEG-R assessment protocol was executed twice per day in adult patients after CA.

174 ction at home at 10 mug/kg or 20 mug/kg once per day in combination with pembrolizumab (2 mg/kg every

175 participants received venetoclax orally once per day in continuous 28-day cycles at either 240 mg/m(2

176 ts received 800 mg tazemetostat orally twice per day in continuous 28-day cycles until disease progre

177 received 800 mg of tazemetostat orally twice per day in continuous 28-day cycles.

178 ing at an approximately two-fold growth rate per day in optimum conditions, U. meridionalis grows at

179 ional ~1.86 cm water equivalent surface melt per day in patches of high algal abundance (~10(4) cells

180 ceived oral doses of enasidenib at 60-300 mg per day in repeated 28-day treatment cycles.

181 ease to receive levodopa (100 mg three times per day) in combination with carbidopa (25 mg three time

182 and marine n-3 fatty acids (at a dose of 1 g per day) in the primary prevention of cardiovascular dis

183 on of 1,25(OH)(2) vitamin D(3) (2 days, once per day) in wild-type and intestinal-specific Slc34a2-de

184 8-ounce (8 fluid ounces = 236.6 mL) serving per day increase in soft drinks was associated with a 1.

185 ible to receive VI (vincristine, 1.5 mg/m(2) per day intravenously on days 1 and 8; irinotecan, 20 mg

186 usly on days 1 and 8; irinotecan, 20 mg/m(2) per day intravenously on days 1-5 and 8-12 of a 21-day c

187 Lancet diets cost a global median of US$2.84 per day (IQR 2.41-3.16) in 2011, of which the largest sh

188 range [IQR], 89-627) and median SGR was 0.3% per day (IQR, 0.1%-0.8%).

189 Watching television for more than 3.5 hours per day is associated with a dose-response decline in ve

190 enabling the fabrication of up to 6048 films per day is introduced.

191 t television viewing for more than 3.5 hours per day is related to cognitive decline.

192 racterize tens of thousands of cell lineages per day, making it possible to accurately screen complex

193 tems with up to 1 m(3)/s (23 million gallons per day) mean water recycling rate, potentially lowering

194 ose (LD-NaHCO(3); 0.5 meq/kg of lean body wt per day; n=52) NaHCO(3) or matching placebo (n=52).

195 ose (HD-NaHCO(3); 0.8 meq/kg of lean body wt per day; n=90) or lower-dose (LD-NaHCO(3); 0.5 meq/kg of

196 s per day) and limited-light (0.41 divisions per day) nutrient replete conditions.

197 of $224,537, which equates to around $10,000 per day of clean-up operations or $8,900 per tonne of li

198 consider how consuming an additional serving per day of each of 15 foods is associated with 5 health

199 Participants received 2 mg per day of loperamide or oral placebo with the option of

200 80, were randomized 1:1 to placebo or 150mg per day of omaveloxolone.

201 red to attain matching release kinetics (~3% per day) of both paclitaxel and everolimus to maintain a

202 hput interrogation (several thousand samples per day) of whole segments of the GI tract.

203 us to reach a throughput of 100 000 samples per day on a single mass spectrometer.

204 A also received veliparib 80 mg orally twice per day on days 1 to 12 cycled every 3 weeks.

205 intravenous bolus of idarubicin (12 mg/m(2) per day on days 1-3).

206 /m(2) per day), and cytarabine (1000 mg/m(2) per day on days 1-5 of up to two 28-day cycles); or intr

207 (or intravenous 5-fluorouracil, 800 mg/m(2) per day on days 1-5), and a 200 mg flat dose of intraven

208 ntinuous infusion of cytarabine (100 mg/m(2) per day on days 1-7) and intravenous bolus of idarubicin

209 idarubicin (intravenous infusion 10 mg/m(2) per day on days 2-4 in up to two 28-day cycles).

210 ytarabine (intravenous infusion 2000 mg/m(2) per day on days 2-6), and idarubicin (intravenous infusi

211 fludarabine (intravenous infusion 30 mg/m(2) per day on days 2-6), cytarabine (intravenous infusion 2

212 Oral alisertib (30 mg) was given twice per day on days 8-15.

213 epared and applied on the enamel three times per day once a week, for 4 weeks.

214 cyte colony-stimulating factor (300 mug/m(2) per day or 5 mug/kg per day subcutaneously on days 1-5),

215 HO targets (a minimum target of 400 g/person per day or age-specific recommendations of 330-600 g/per

216 Treatment consisted of pazopanib 800 mg once per day or doxorubicin 75 mg/m(2) once every 3 weeks (<=

217 ociations of ever smoked, but not cigarettes per day or duration, with specific GM and WM regions.

218 ogical precipitation is about one millimetre per day or more.

219 ceive either 200 mg oral thiamin mononitrate per day or placebo for 6 mo.

220 administered daily deferiprone (75-100 mg/kg per day) or daily deferasirox (20-40 mg/kg per day) admi

221 and were receiving deferoxamine (<100 mg/kg per day) or deferasirox (<40 mg/kg per day; deferasirox

222 assigned (2:1) to receive PF-04457845 (4 mg per day) or placebo using a fixed block size of six part

223 randomly assigned to rucaparib (600 mg twice per day) or placebo.

224 ase inhibitor therapy, to doravirine (100 mg per day) or ritonavir-boosted darunavir (100 mg ritonavi

225 14 days of supervised primaquine (0.5 mg/kg per day), or placebo.

226 1:1 ratio to placebo, fenfluramine 0.2 mg/kg per day, or fenfluramine 0.7 mg/kg per day, added to exi

227 creatine per day, 400 mug FA + 3 g creatine per day, or placebo.

228 o consume pomegranate juice [8 oz (236.5 mL) per day] or a placebo drink (8 oz, matched constituents

229 went a pretreatment biopsy, 6 months of once per day oral talazoparib (1 mg), followed by definitive

230 y assigned (1:1) to either anastrozole (1 mg per day, oral) or matching placebo daily for 5 years.

231 eived a loading dose of 1000 mg pexidartinib per day orally (400 mg morning; 600 mg evening) for the

232 recommended phase II dose: venetoclax 600 mg per day orally in 28-day cycles, with LDAC (20 mg/m(2) p

233 mly assigned (2:1) to POAI (letrozole 2.5 mg per day orally or anastrozole 1 mg per day orally) for 1

234 le 2.5 mg per day orally or anastrozole 1 mg per day orally) for 14 days before and following surgery

235 size of three to receive venetoclax (800 mg per day orally) or placebo with bortezomib (1.3 mg/m(2)

236 The initial sorafenib dose was 400 mg twice per day orally, amended to 400 mg daily.

237 capacity decay of 0.014% per cycle and 0.16% per day over 1000 cycles.

238 ed 30 Gy delivered in 1.5-Gy fractions twice per day over 2 weeks along with 15 mg/m(2) docetaxel onc

239 Play fighting was recorded for 1.5 h per day over 6 days pre-weaning.

240 bjects consuming one more pack of cigarettes per day (P (Interaction) = 1.9 x 10(-7)).

241 05), but not with the number of active bouts per day (P = 0.30).

242 ; 95% CI, -2.8% to -1.1% [-40 to -16 minutes per day]; P <.001).

243 ociation with smoking initiation, cigarettes per day, pack-years, and smoking cessation in a fixed ef

244 lly per day (Gef) or gefitinib 250 mg orally per day plus pemetrexed 500 mg/m(2) and carboplatin area

245 c agents (fructo-oligosaccharides, 4 g twice per day, plus Bifidobacterium animalis subspecies lactis

246 on dioxide equivalent (kg CO2-eq) per person per day (pppd); 2030: 2.04 kg CO2-eq pppd; less strict 2

247 r (LCA) to determine patient activity (steps per day) preoperatively (baseline) and up to one year (Y

248 l-Carnitine administration (0.9 g/kg per day) prevented atrophy over the first 2 weeks, and m

249 1.8%) and consumed an average of five drinks per day prior to entering the study.

250 well as stronger in consumers of high (>20 g per day) quantities of alcohol than in those consuming l

251 n in those consuming low-to-moderate (<=20 g per day) quantities.

252 7% (68 minutes per day) and 4.9% (70 minutes per day), respectively, in the standard BGM group (adjus

253 ogram per day and 29.5+/-3.6 mg per kilogram per day, respectively.

254 llowed for 48 and 96 patients to be injected per day, respectively.

255 oportion of families earning less than $1.90 per day rose from five (0.2%, 0.0-0.5) of 2422 to 992 (4

256 ded regimen, 166 were allocated to the 60 mg per day screen-and-treat approach, and 165 were allocate

257 pproach, and 165 were allocated to the 30 mg per day screen-and-treat approach.

258 Drinking >=1.5 drinks per day showed a trend toward harm (HR = 1.16, 95% CI 0.

259 ing factor (300 mug/m(2) per day or 5 mug/kg per day subcutaneously on days 1-5), fludarabine (intrav

260 Compared with taking 4000 steps per day, taking 8000 steps per day was associated with s

261 d to receive verubecestat at a dose of 12 mg per day (the 12-mg group), 484 to receive verubecestat a

262 4 to receive verubecestat at a dose of 40 mg per day (the 40-mg group), and 485 to receive placebo.

263 ~1 km(2) and perennial motions at ~10-20 mm per day, the Slumgullion landslide in Colorado, USA, rep

264 ed control starch with three identical diets per day throughout the study.

265 ces in the secondary outcomes of step counts per day, time spent in moderate or vigorous activity, ti

266 We compared total diet cost per day to each country's mean per capita household inco

267 lf-life in the blood requires two injections per day to maintain effective glycemic control.

268 In recovery from a twice per day training protocol where muscle glycogen concentr

269 ) followed by continuous infusion (300 mg/kg per day) until discharge.

270 s throughput of 9.6, 16, and 24 single cells per day using 120, 60, and 30 min LC gradients, respecti

271 specific recommendations of 330-600 g/person per day) using population pyramids; for future consumpti

272 eating window to a specified number of hours per day (usually 4-10 h), and fasting (with zero-calorie

273 oral baclofen greater than or equal to 20 mg per day vs less than 20 mg per day.

274 The mean number of platelet units requested per day was 16.2 (range 0-30); 5.1 (range 0-15) were rec

275 The mean number of steps per day was 9124.

276 The average number of hours worked per day was a positive factor for burnout, while being m

277 take of 175 mg per day, an intake of 1000 mg per day was associated with a 14% lower risk of atherosc

278 IDH1 advanced glioma, ivosidenib 500 mg once per day was associated with a favorable safety profile,

279 ion analysis, smoking 0.5 pack of cigarettes per day was associated with a statistically significant

280 taking 4000 steps per day, taking 8000 steps per day was associated with significantly lower all-caus

281 ntal cost to the NHS per 1,000-step increase per day was pound 96 and to society was pound 239.

282 ion of 2 new patient (or 3 returning) visits per day was profitable for all specialties.

283 tolerated dose was not reached; 500 mg once per day was selected for the expansion cohort.

284 ional 300 mg of dietary cholesterol consumed per day was significantly associated with higher risk of

285 Each additional half an egg consumed per day was significantly associated with higher risk of

286 PDE9a inhibitor (5 and 8 mg/kg per day) was administered to the mice via subcutaneously

287 0 years, consumed 3 or more alcoholic drinks per day, was a high school graduate, had a family histor

288 of pregnancy, even as low as 1-2 cigarettes per day, was associated with an increased risk of preter

289 e geotracking data of 15 million smartphones per day, we found that US counties that voted for Donald

290 nt was -6.6 decibels (dB), and average steps per day were 5613+/-3158.

291 at least five moderate or severe hot flushes per day were allocated to receive four weeks of OLP for

292 Mean +/- SD servings per day were not different by intervention sequence: 2.5

293 DT (169 days; IQR 74-408 days) and SGR (0.4% per day) were similar in an independent cohort (n = 176

294 uent VEGF TrapR(1)R(2) eye drops three times per day whereas the monotherapy group was treated only w

295 rates averaged 132 plastics per square meter per day, which amounts to >1000 metric tons of plastic d

296 astfeed lose an average of 210 mg of calcium per day, which doubles or triples with twins and triplet

297 ol groups in the mean number of waking hours per day with good symptom control and no troublesome dys

298 on's disease who had 2 h or more of off time per day with predictable morning off periods, were respo

299 roximately 20 mg per kilogram of body weight per day) with dose escalation (approximately 30 mg per k

300 nib at a dose of at least 600 mg orally once per day, with at least 12 months' follow-up.